NTRA Q2 2022 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena

NTRANatera, Inc.

$29B

Q2 2022 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$198M+39.6% YoY

Gross Profit

$89M44.9% margin

Operating Income

-$143M-72.2% margin

Net Income

-$145M-73.2% margin

EPS (Diluted)

$-1.50

QoQ Revenue Growth

+2.1%

Cash Flow

Operating Cash Flow

-$111M

Free Cash Flow

-$119M

Stock-Based Comp.

$41M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$622M

Stockholders' Equity

$445M

Cash & Equivalents

$91M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$198M	$142M	+39.6%
Gross Profit	$89M	$66M	+35.0%
Operating Income	-$143M	-$115M	-24.1%
Net Income	-$145M	-$116M	-25.1%

Revenue Segments

Product

$195M98%

Licensing and other

$4M2%

Geographic Segments

United States

$192M97%

Europe, Middle East, India, Africa

$4M2%

Asia Pacific and Other

$2M1%

Americas, excluding U.S.

$530,0000%